Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Loniten
Active Ingredient: Minoxidil 10mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Patheon Inc, Ontario, Canada
Note: This consent is valid for two years from the date of publication of this notice.
Product: Metaraminol
Active Ingredient: Metaraminol tartrate 0.949g/L equivalent to metaraminol base 0.50g
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This consent is valid for two years from the date of publication of this notice.
Product: Metaraminol
Active Ingredient: Metaraminol tartrate 1.898g/L equivalent to metaraminol base 1.0g
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 7th day of April 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).